Our mission is to help patients access life-saving therapies by transforming the drug development journey. Download the "Putting the patient first" report from our leadership roundtable: https://ow.ly/94MP50SpvvE
Norstella’s Post
More Relevant Posts
-
White Paper - Preparing for the At-Home Diagnostic Testing Revolution ixlayer At-home diagnostic testing is at the forefront of digital healthcare trends and has expanded exponentially across health issues. So, why should biopharma companies get involved in at-home testing and what are best practices to ensure success? Read Now: https://lnkd.in/dC9bQTvS
Build stronger connections with patients
go.ixlayer.com
-
Having the opportunity to contribute to this comprehensive and important report, alongside such a wonderful team of experts, has been an absolute honour. The third report in our "New Medicines, Novel Insights" thought leadership series offers strategies for sponsors on fully integrating patients into the drug development process, optimizing trial protocols using patient insights, planning early for diversity and overcoming barriers to participation. Hear from our Chief Patient Officer Clare Grace on what a patient-guided approach looks like, and dive into the report to explore our strategies: https://lnkd.in/eXWaeccq #PatientsFirst
-
In Parexel's latest edition of the New Medicines, Novel Insights newsletter, @Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics
To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy
share.parexel.social
-
In Parexel's latest edition of the New Medicines, Novel Insights newsletter, @Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics
To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy
share.parexel.social
-
In Parexel's latest edition of the New Medicines, Novel Insights newsletter, @Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics
To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy
share.parexel.social
-
In Parexel's latest edition of the New Medicines, Novel Insights newsletter, @Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics
To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy
share.parexel.social
-
Though many drug manufacturers tend to think of launch day as a single point in time, the journey from R&D to market success is more akin to a marathon than a sprint. Spherico, a division of GSW, powered by Syneos Health SVP Leana Katz and GENICOS, powered by Syneos Health SVP Cathy Eschenbach dive into the tips to help you ensure that your organization is race-day ready when it comes to launching a new therapy. Learn more: https://bit.ly/3ZC7Y61 #HeartofHealth #DrugLaunches #LaunchPlanning
-
-
Matching top talent to meaningful careers at Parexel #withheart 💜 Recruiting positions for US, Canada and EMEA
In Parexel's latest edition of the New Medicines, Novel Insights newsletter, @Alex Gee, Senior Director, Parexel Access Consulting, shares the keys to establishing market access, why patient insights are essential, and how every drug developer can benefit from bringing access experts in by phase II. Learn how to demonstrate clinical and economic value, positioning your product for favorable coverage decisions that benefit the appropriate patient population. Like and subscribe to stay updated with more #NovelInsights! #MarketAccess #PatientEngagement #Reimbursement #HealthEconomics
To establish market access, start with unmet need: Why patient insights are central to reimbursement strategy
share.parexel.social
Chief Executive Officer at USA and International Research Inc.
3wExcited to explore how your leadership roundtable is putting patients first in drug development! Downloading the report now to learn more.